Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation

Journal of Heart and Lung Transplantation

Volumn 24, Issue 3, 2005, Pages 347-349

  Kogan, Alexander ^a   Berman, Marius ^a   Kassif, Ygal ^a   Raanani, Ehud ^a   Stamler, Alon ^a   Ben Gal, Tuvia ^a   Stein, Michael ^a,b   Erez, Eldad ^a   Vidne, Bernardo A ^a   Sahar, Gideon ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLEEDING; CASE REPORT; HEART ASSIST DEVICE; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 20044396525     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.12.001     Document Type: Short Survey

References (11)

1. Hedner U. Recombinant factor VIIa (NovoSeven) as a hemostatic agent. Semin Hematol. 38:2001;43-47
2. Moscardo F., Perez F., Rubia J., et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol. 113:2001;174-176
3. Martinowitz U., Kenet G., Segal E., et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma. 51:2001;431-438
4. Al Douri M., Shafi T., Al Khudari D., et al. Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinolysis. 11:2000;S121-S127
5. Hendriks H.G.D., van der Maaten J.A., de Wolf J., et al. An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg. 93:2001;287-289
6. Ko W.J., Lin C.Y., Chen R.J., Wang S.S., Lin F.Y., Chen Y.S. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg. 73:2002;538-545
7. Monroe D.M., Hoffman M., Oliver J.A., Roberts H.R. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol. 99:1997;542-547
8. Kastrup M., von Heymann C., Hotz H., et al. Recombinant factor rFVIIa after aortic valve replacement in a patient with osteogenesis imperfecta. Ann Thorac Surg. 74:2002;910-912
9. Zietkiewicz M., Garlicki M., Domagala J., et al. Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with left ventricular assist device. J Thorac Cardiovasc Surg. 123:2002;384-385
10. Potapov E.V., Pasic M., Bauer M., Hetzer R. Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device. Ann Thorac Surg. 74:2002;2182-2183
11. Bui J.D., Despotis G.D., Trulock E.P., Patterson G.A., Goodnough L.T. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg. 124:2002;852-854